Suppr超能文献

退伍军人事务部医疗保健系统中,非致命性阿片类药物过量后阿片类药物使用障碍医疗治疗中的种族/族裔差异。

Racial/Ethnic Differences in the Medical Treatment of Opioid Use Disorders Within the VA Healthcare System Following Non-Fatal Opioid Overdose.

作者信息

Essien Utibe R, Sileanu Florentina E, Zhao Xinhua, Liebschutz Jane M, Thorpe Carolyn T, Good Chester B, Mor Maria K, Radomski Thomas R, Hausmann Leslie R M, Fine Michael J, Gellad Walid F

机构信息

Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, PA, USA.

Division of General Internal Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

出版信息

J Gen Intern Med. 2020 May;35(5):1537-1544. doi: 10.1007/s11606-020-05645-0. Epub 2020 Jan 21.

Abstract

BACKGROUND

After non-fatal opioid overdoses, opioid prescribing patterns are often unchanged and the use of medications for opioid use disorder (MOUDs) remains low. Whether such prescribing differs by race/ethnicity remains unknown.

OBJECTIVE

To assess the association of race/ethnicity with the prescribing of opioids and MOUDs after a non-fatal opioid overdose.

DESIGN

Retrospective cohort study.

PARTICIPANTS

Patients prescribed ≥ 1 opioid from July 1, 2010, to September 30, 2015, with a non-fatal opioid overdose in the Veterans Health Administration (VA).

MAIN MEASURES

Primary outcomes were the proportion of patients prescribed: (1) any opioid during the 30 days before and after overdose and (2) MOUDs within 30 days after overdose by race and ethnicity. We conducted difference-in-difference analyses using multivariable regression to assess whether the change in opioid prescribing from before to after overdose differed by race/ethnicity. We also used multivariable regression to test whether MOUD prescribing after overdose differed by race/ethnicity.

KEY RESULTS

Among 16,210 patients with a non-fatal opioid overdose (81.2% were white, 14.3% black, and 4.5% Hispanic), 10,745 (66.3%) patients received an opioid prescription (67.1% white, 61.7% black, and 65.9% Hispanic; p < 0.01) before overdose. After overdose, the frequency of receiving opioids was reduced by 18.3, 16.4, and 20.6 percentage points in whites, blacks, and Hispanics, respectively, with no significant difference-in-difference in opioid prescribing by race/ethnicity (p = 0.23). After overdose, 526 (3.2%) patients received MOUDs (2.9% white, 4.6% black, and 5.5% Hispanic; p < 0.01). Blacks (adjusted OR (aOR) 1.6; 95% CI 1.2, 1.9) and Hispanics (aOR 1.8; 95% CI 1.2, 2.6) had significantly larger odds of receiving MOUDs than white patients.

CONCLUSIONS

In a national cohort of patients with non-fatal opioid overdose in VA, there were no racial/ethnic differences in changes in opioid prescribing after overdose. Although blacks and Hispanics were more likely than white patients to receive MOUDs in the 30 days after overdose, less than 4% of all groups received such therapy.

摘要

背景

在非致命性阿片类药物过量使用后,阿片类药物的处方模式通常没有变化,用于阿片类药物使用障碍(MOUDs)的药物使用率仍然很低。这种处方是否因种族/族裔不同而存在差异尚不清楚。

目的

评估非致命性阿片类药物过量使用后种族/族裔与阿片类药物及MOUDs处方之间的关联。

设计

回顾性队列研究。

参与者

2010年7月1日至2015年9月30日期间在退伍军人健康管理局(VA)开具过≥1种阿片类药物且有非致命性阿片类药物过量使用的患者。

主要测量指标

主要结局是按种族和族裔划分的患者比例:(1)过量使用前后30天内开具任何阿片类药物的患者比例;(2)过量使用后30天内接受MOUDs治疗的患者比例。我们使用多变量回归进行差异分析,以评估过量使用前后阿片类药物处方的变化是否因种族/族裔而异。我们还使用多变量回归来检验过量使用后MOUDs处方是否因种族/族裔而异。

关键结果

在16210例非致命性阿片类药物过量使用患者中(81.2%为白人,14.3%为黑人, 4.5%为西班牙裔),10745例(66.3%)患者在过量使用前接受了阿片类药物处方(白人67.1%,黑人61.7%,西班牙裔65.9%;p<0.01)。过量使用后,白人、黑人和西班牙裔接受阿片类药物的频率分别降低了18.3、16.4和20.6个百分点,阿片类药物处方在种族/族裔方面没有显著的差异(p = 0.

相似文献

7
Racial inequities in U.S. naloxone prescriptions.美国纳洛酮处方中的种族不平等现象。
Subst Abus. 2020;41(2):232-244. doi: 10.1080/08897077.2019.1686721. Epub 2019 Nov 13.

引用本文的文献

本文引用的文献

4
Buprenorphine Treatment Divide by Race/Ethnicity and Payment.美沙酮治疗按种族/民族和支付方式划分。
JAMA Psychiatry. 2019 Sep 1;76(9):979-981. doi: 10.1001/jamapsychiatry.2019.0876.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验